People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Healthtech, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Supira Medical, Inc. | — | Healthtech | Series D+ | $220.7M | $1.1B | 2017 |
| Akura Medical, Inc. | — | Healthtech | Series C | $94.8M | $299.4M | 2025 |
| Tioga Cardiovascular, Inc. | — | Other Health Care | Series B | $69.8M | $105.6M | 2025 |
| Atia Vision, Inc. | — | Biotechnology | Series B | $51.0M | $466.4M | 2018 |
| Laza Medical, Inc. | — | Biotechnology | Series B | $25.5M | $235.0M | 2023 |
| NuVera Medical, Inc. | — | Biotechnology | Series A | $11.7M | $423.0M | 2017 |
Mariam Maghribi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mariam Maghribi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| AMR SALAHIEH | 6 | 10 |
| BIHUA CHEN | 4 | 14 |
| Casey Gordon | 3 | 4 |
| Gautam Kainth | 2 | 3 |
| Henry Chen | 1 | 7 |
| Christopher Shen | 1 | 2 |
| Casey Garcia Gordon | 1 | 1 |
| Pablo Garcia Kilroy | 1 | 1 |
| David Garcia Voris | 1 | 1 |
| Claudio Argento | 1 | 1 |
| David Voris | 1 | 1 |
| Murali Srivathsa | 1 | 1 |
| Michael Dineen | 1 | 1 |
| Nitin Salunke | 1 | 1 |
| Jean Orth | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.